Scientists say a newly developed drug has the potential to stop a debilitating condition of diabetes that often leads to pain in the extremities and even amputations.
The drug has been developed at the University of Kansas.
Diabetes
A comprehensive article on diabetes - both Type 1 and Type 2 diabetes, including : causes, signs, symptoms, diagnosis, treatment, facts and a glossary on diabetes.
Advertisement
The researchers have found that KU-32 can stop and even reverse diabetic peripheral neuropathy, or DPN, in mice.
The condition leads to death of nerves in the extremities of individuals with diabetes.
"People with DPN can be very sensitive to light touch, which can cause significant pain," said Rick Dobrowsky, one of the paper's authors.
![Diabetes - Foot Care]( "Diabetes - Foot Care")
"The other side is eventually diabetes causes death of the nerves. DPN often leads to loss of feeling in the hands and feet, which can make diabetics susceptible to wounds and infections and often leads to amputations of toes and feet," he said.
The researchers administered KU-32 to diabetic mice. The compound stopped DPN and showed it could restore sensory neuron function to damaged nerve tissue. KU-32 inhibits a specific member of a family of proteins called molecular chaperones.
"These studies provide the first evidence that targeting molecular chaperones reverses the sensory hypoalgesia associated with DPN," the authors wrote.
"Our tests so far indicate that KU-32 is completely nontoxic and is absorbed in the blood stream very well," said Brian Blagg.
The article, "Inhibiting heat-shock 90 protein 90 reverses sensory hypoalgesia in diabetic mice," appeared on the ASN Neuro site.
Source: ANI
"People with DPN can be very sensitive to light touch, which can cause significant pain," said Rick Dobrowsky, one of the paper's authors.
Advertisement
"The other side is eventually diabetes causes death of the nerves. DPN often leads to loss of feeling in the hands and feet, which can make diabetics susceptible to wounds and infections and often leads to amputations of toes and feet," he said.
The researchers administered KU-32 to diabetic mice. The compound stopped DPN and showed it could restore sensory neuron function to damaged nerve tissue. KU-32 inhibits a specific member of a family of proteins called molecular chaperones.
"These studies provide the first evidence that targeting molecular chaperones reverses the sensory hypoalgesia associated with DPN," the authors wrote.
"Our tests so far indicate that KU-32 is completely nontoxic and is absorbed in the blood stream very well," said Brian Blagg.
The article, "Inhibiting heat-shock 90 protein 90 reverses sensory hypoalgesia in diabetic mice," appeared on the ASN Neuro site.
Source: ANI
Diabetes Risk Assessment Calculator
Almost one-third of the people are unaware of the risk factors of diabetes. Find out if you run the risk of diabetes by using Diabetes Risk Assessment calculator.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Diabetes News
In type 2 diabetes individuals, regular screening for two key cardiac biomarkers may decrease the risk of cardiovascular disease events.
The US Food and Drug Administration (FDA) clears the 'bionic pancreas' that improves the management of type 1 diabetes, without the need for constant blood sugar testing.
A new study investigated the use of a mathematical model of glucose metabolism to assess continuous glucose monitor data as a metric of dysfunctional glycemic control.
At least 400 medicinal plants effective in decreasing sugar levels in the blood which is critical to control type 2 diabetes identified.
Considering the enormous type 2 diabetes patient population in China, a new oral insulin therapy will improve treatment.